Armed Cell Therapeutics

Deals and Financing

Mankind Pharma Acquires Majority Stake in Armed Cell Therapeutics

Mankind Pharma, through its Dutch subsidiary, signed a definitive agreement to invest EUR48 million for a 70% stake in Armed Cell Therapeutics. The newly formed Belgian company holds a preclinical portfolio of multi-targeting and…

admin
October 15, 2026

Deals and Financing

Armed Cell Acquires Lakefront Preclinical CAR T Portfolio

Lakefront Biotherapeutics completed the sale of its preclinical multi-targeting and armed CAR-T portfolio to newly formed Armed Cell Therapeutics. Lakefront receives €8 million upfront, may earn up to $230 million in milestones and retains…

admin
October 15, 2026

Mankind Pharma Acquires Majority Stake in Armed Cell Therapeutics

Armed Cell Acquires Lakefront Preclinical CAR T Portfolio

Saturday Rounds